Literature DB >> 15616325

Increased expression of two multidrug transporter-like genes is associated with ethidium bromide and ciprofloxacin resistance in Mycoplasma hominis.

S Raherison1, P Gonzalez, H Renaudin, A Charron, C Bébéar, C M Bébéar.   

Abstract

Two genes, md1 and md2, coding for multidrug resistance ATP-binding cassette transporters were identified in Mycoplasma hominis PG21. Expression of these two genes, quantified by quantitative competitive reverse transcription-PCR, was significantly increased in ethidium bromide-resistant strains of M. hominis compared to that in M. hominis PG21.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15616325      PMCID： PMC538859          DOI： 10.1128/AAC.49.1.421-424.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

1.  Microbial genome analyses: comparative transport capabilities in eighteen prokaryotes.

Authors:  I T Paulsen; L Nguyen; M K Sliwinski; R Rabus; M H Saier
Journal:  J Mol Biol       Date:  2000-08-04       Impact factor: 5.469

2.  Role of mobile DNA in the evolution of vancomycin-resistant Enterococcus faecalis.

Authors:  I T Paulsen; L Banerjei; G S A Myers; K E Nelson; R Seshadri; T D Read; D E Fouts; J A Eisen; S R Gill; J F Heidelberg; H Tettelin; R J Dodson; L Umayam; L Brinkac; M Beanan; S Daugherty; R T DeBoy; S Durkin; J Kolonay; R Madupu; W Nelson; J Vamathevan; B Tran; J Upton; T Hansen; J Shetty; H Khouri; T Utterback; D Radune; K A Ketchum; B A Dougherty; C M Fraser
Journal:  Science       Date:  2003-03-28       Impact factor: 47.728

3.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters.

Authors:  G Chang; C B Roth
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

4.  Hop resistance in the beer spoilage bacterium Lactobacillus brevis is mediated by the ATP-binding cassette multidrug transporter HorA.

Authors:  K Sakamoto; A Margolles; H W van Veen; W N Konings
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

5.  Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis.

Authors:  C M Bebear; J Renaudin; A Charron; H Renaudin; B de Barbeyrac; T Schaeverbeke; C Bebear
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

6.  Expression of efflux pump gene pmrA in fluoroquinolone-resistant and -susceptible clinical isolates of Streptococcus pneumoniae.

Authors:  Laura J V Piddock; Maggie M Johnson; S Simjee; L Pumbwe
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

7.  Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Authors:  S Raherison; P Gonzalez; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Molecular cloning and characterization of an ABC multidrug efflux pump, VcaM, in Non-O1 Vibrio cholerae.

Authors:  Nazmul Huda; Eun-Woo Lee; Jing Chen; Yuji Morita; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

9.  EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis.

Authors:  Eun-Woo Lee; M Nazmul Huda; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883
View more
  7 in total

Review 1.  Xenobiotic efflux in bacteria and fungi: a genomics update.

Authors:  Ravi D Barabote; Jose Thekkiniath; Richard E Strauss; Govindsamy Vediyappan; Joe A Fralick; Michael J San Francisco
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  2011

2.  Alterations in the Quinolone Resistance-Determining Regions and Fluoroquinolone Resistance in Clinical Isolates and Laboratory-Derived Mutants of Mycoplasma bovis: Not All Genotypes May Be Equal.

Authors:  Dima Khalil; Claire A M Becker; Florence Tardy
Journal:  Appl Environ Microbiol       Date:  2015-12-04       Impact factor: 4.792

3.  Potential of 1-(1-napthylmethyl)-piperazine, an efflux pump inhibitor against cadmium-induced multidrug resistance in Salmonella enterica serovar Typhi as an adjunct to antibiotics.

Authors:  Ujjwal Jit Kaur; Adity Chopra; Simran Preet; Khem Raj; Kanthi Kiran Kondepudi; Varsha Gupta; Praveen Rishi
Journal:  Braz J Microbiol       Date:  2021-04-13       Impact factor: 2.476

4.  Mycoplasma Contamination of Cell Cultures: Vesicular Traffic in Bacteria and Control over Infectious Agents.

Authors:  V M Chernov; O A Chernova; J T Sanchez-Vega; A I Kolpakov; O N Ilinskaya
Journal:  Acta Naturae       Date:  2014-07       Impact factor: 1.845

5.  Mycoplasmas and Their Antibiotic Resistance: The Problems and Prospects in Controlling Infections.

Authors:  O A Chernova; E S Medvedeva; A A Mouzykantov; N B Baranova; V M Chernov
Journal:  Acta Naturae       Date:  2016 Apr-Jun       Impact factor: 1.845

6.  The Genome Structure of Ciprofloxacin-Resistant Mycoplasma Hominis Clinical Isolates.

Authors:  E A Kolesnikova; N F Brusnigina; M A Makhova; A E Alekseeva
Journal:  Acta Naturae       Date:  2020 Jan-Mar       Impact factor: 1.845

7.  Mycoplasma-associated multidrug resistance of hepatocarcinoma cells requires the interaction of P37 and Annexin A2.

Authors:  Danyang Liu; Yang Hu; Ying Guo; Zhu Zhu; Bingzheng Lu; Xuelan Wang; Yijun Huang
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.